Singapore’s Engine Biosciences Raises $43 Million to Decipher Genetic Codes for New Medicines

Singapore – June 17, 2021 – Cooley advised Engine Biosciences, a company deciphering complex biology to create medicines, on its $43 million Series A financing round. A Cooley team led by Singapore-based partner Matthew Bartus advised Engine Biosciences on the transaction.

Polaris Partners led the round, which also included participation from Invus, 6 Dimensions Capital, WuXi AppTec, DHVC, EDBI, Baidu Ventures, Vectr Ventures, Goodman Capital, WI Harper and Nest.Bio. Engine Biosciences will use the new capital to expand its portfolio of precision oncology therapeutics, prepare for its first clinical programs and scale its proprietary technology platform.

“We are honored that this preeminent group of life science and technology investors has recognized the progress our team has made and is supporting our mission to unleash new medicines by deciphering biology,” Jeffrey Lu, co-founder and CEO of Engine Biosciences, said in a news release.

Located in Singapore and Silicon Valley, Engine Biosciences operates at the intersection of data science, machine learning, high-throughput biology experimentation, combinatorial genetics, chemistry and drug discovery. Its technologies enable researchers and drug developers to uncover the gene interactions and biological networks underlying diseases faster and more cost-effectively than conventional methods.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,200 lawyers across 17 offices in the United States, Asia and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.